3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Multiple Myeloma
2
Lymphoma
2
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Cancer Related Cognitive Difficulties
1
Interventions
Rituximab
15
Cyclophosphamide
10
Lenalidomide
8
venetoclax
7
Magnetic Resonance Spectroscopy
7
obinutuzumab
5
ibrutinib
5
Specimen Handling
5
Prednisone
5
fludarabine phosphate
4
fludarabine
4
Whole-Body Irradiation
4
Vincristine
4
CT-P10
4
Biopsy
4
zanubrutinib
3
orelabrutinib
3
Mycophenolic Acid
3
Doxorubicin
3
Cyclosporine
3
polatuzumab vedotin
2
pirtobrutinib
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Etoposide
2
Busulfan
2
Bendamustine Hydrochloride
2
voruciclib
1
treosulfan
1
tafasitamab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
Neuropsychological Tests
×
90 days
×
Clear all
NCT07558057
2026-04-30
COGNITOX
University of Aarhus
Not yet recruiting
225 enrolled